Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AS-AQ, AR-LM, and AS-LP in children with malaria in Ghana
NCT00119145Phase 4Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of artesunate + amodiaquine, artemether + lumefantrine, chlorproguanil + dapsone + artesunate in Plasmodium falciparum malaria, sponsored by London School of Hygiene & Tropical Medicine. Started Jun 2005; status: completed.
02
Drugs
artesunate + amodiaquineartemether + lumefantrinechlorproguanil + dapsone + artesunate
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT00119145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00119145.